MedTrace Logo

Pain Management in Head and Neck Surgery Patients

NCT03121963 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2021-06-22

No results posted yet for this study

Summary

Our study aims to see if the addition of a scheduled non-opioid pain regimen will decrease the use and risk of opioid pain medications as well as improve pain control in head and neck surgery patients. Participants will be randomized to one of two pain regimens (opioid medication regimen vs combination regimen of opioid and non-opioid medications).

Conditions

  • Pain Management

Interventions

DRUG

Oxycodone

oxycodone tablet

DRUG

Acetaminophen

acetaminophen tablet

DRUG

Gabapentin

gabapentin tablet

DRUG

Celecoxib

celecoxib tablet

DRUG

Hydrocodone-Acetaminophen

hydrocodone 5 mg/acetaminophen 325 mg tablet

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Erin Partington Buczek, MD · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-10
Primary Completion
2020-11-06
Completion
2021-11-06
FDA Drug
Yes

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03121963 on ClinicalTrials.gov